Identifying CDC7 as a Synergistic Target of Chemotherapy in Resistant Small-Cell Lung Cancer via CRISPR/Cas9 Screening

Scientists examined a chemo-resistant SCLC cell line using genome-wide CRISPR/Cas9 screening and identified serine/threonine kinase cell division cycle 7 (CDC7) as a potential synergistic target.